Aridis Pharmaceuticals

ARDS

0.0002100.00% ( +0.0001 )

Delay Closed: Oct 23, 16:00:00 (EDT)

Q3 FY2023 Earnings

Financial report interval: 2023.06.30 - 2023.09.30

Overview: Aridis Pharmaceuticals(ARDS) the Revenue is 417 K (+4.51%), Miss estimate;the EBIT is -869 K (+88.28%), Beat estimate;the EPS is 0 (+100%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueMiss expectations

0.00B4.51%

0.00B275.94%

-0.00B271.43%

EBITExceed expectations

-0.00B88.28%

-0.00B43.34%

+0.00B44.94%

EPSExceed expectations

0100.00%

-0.178.72%

+0.100021.28%

Revenue

ActualEstimateUnit: USD

Quarterly

EBIT

ActualEstimateUnit: USD

Quarterly

Net income

ActualEstimateUnit: USD

Quarterly

EPS

ActualEstimateUnit: USD

Quarterly